Prescription Drug Abuse and Diversion Training Conference

Altoona, PA US
May 12, 2022

The topics provided in this training will assist professionals further and provide resources in addressing the current issues with drug addiction treatment. A better understanding of the PA Medical Marijuana program will help professionals better handle those patients who are prescribed medical marijuana. The PDMP is very important in helping curve overprescribing of medications. Explaining and providing insight on the new PDMP will help professionals see and understand the importance of the system.

Target Audience

The target audience for this training includes medical professionals, first responders, law enforcement and compliance investigators.

Learning Objectives

The objective of this training is to provide training and education to medical professionals on different drug treatment options for patients, a better understanding of the PA Medical Marijuana program, and an overview of the current updated Pennsylvania Prescription Drug Monitoring Program. Current Drug Trends will also be presented providing insight on current issues the attendees might see on a daily basis at work and help them be prepared for such trends.

Additional Information

AttachmentSize
PDF icon Audience Disclosure (FINAL).pdf167.07 KB
Course summary
Available credit: 
  • 6.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 6.75 Attendance
Course opens: 
04/19/2022
Course expires: 
12/31/2022
Event starts: 
05/12/2022 - 8:30am EDT
Event ends: 
05/12/2022 - 4:30pm EDT

Agenda

7:30 AM -   8:30 AM     Registration – Continental Breakfast 

8:30 AM -   8:45 AM     Opening Remarks 
Charlie Cichon, NADDI Executive Director
Matt Massaro, NADDI PA State Chapter President 

8:45 AM -   9:45 AM     LETI (Law Enforcement Training Initiative) - Dr. Janene Holter, PA Office of Attorney General

9:45 AM         Break 

10:00 AM - 11:00 AM     “Bridging the Gap” - Drew Neel, Blair Drug and Alcohol Partnerships

11:00 AM         Break 

11:15 AM - 12:15 PM     Medical Marijuana - Craig Amos, Pennsylvania DUI Association 

12:15 PM -   1:15 PM     Lunch – Provided by NADDI 

1:15 PM -   2:15 PM     Pennsylvania Office of Drug Surveillance and Misuse Prevention PDMP (Prescription Drug Monitoring Program) - Stanley Murzynski, Senior Project Manager

2:15 PM         Break
 
2:30 PM -   3:15 PM     Current Drug Trends - Steve Denhup, DEA Intelligence Group Supervisor

3:15 PM         Break 

3:30 PM -   4:30 PM     Substance Abuse as a Medical Disease - Dr. Zane Gates, People One Health

4:30 PM -   5:00 PM    Closing Remarks - Matt Massaro

5:00 PM        Adjournment

Blair County Convention Center
​​​​​​​1 Convention Center Drive
Altoona, PA 16602
United States

Faculty Listing:
Matthew Massaro, Narcotics Agent
PA Office of Attorney General
State College, PA

Charlie Cichon, Executive Director
NADDI (National Association of Drug Diversion Investigators)
Lutherville-Timonium, MD

Dr. Janene Holter
PA Office of Attorney General
Wilkes-Barre, PA

Drew Neel
Blair Drug and Alcohol Partnerships
Altoona, PA

Craig Amos
Pennsylvania DUI Association 
Harrisburg, PA

Stanley Murzynski, Senior Project Manager
Pennsylvania Office of Drug Surveillance and Misuse Prevention 
Harrisburg, PA

Steve Denhup
DEA Intelligence Group Supervisor 
Pittsburgh, PA

Zane Gates, MD
People One Health 
Altoona, PA

Faculty Disclosure:
No members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships with any companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.

In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and National Association of Drug Diversion Investigators (NADDI). The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician (CME)
The University of Pittsburgh designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 6.75 contact hours.

Pharmacy (CPE)
This knowledge-based activity provides 6.25 contact hours of continuing pharmacy education credit.  

Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 6.25 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 6.75 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 6.75 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 6.75 Attendance
Please login or register to take this course.

Conference Registration Information

The PA Chapter if NADDI (National Association of Drug Diversion Investigators) is holding a one day training at the Blair County Convention Center on May 12th. Blair County Drug and Alcohol has provided grant money for Blair County medical professionals to attend for free on a first come first serve basis. CE credits for the training are being applied for. If anyone is interested in attending, please register at the below link.  Any questions please contact Agent Massaro at:  mmassaro@attorneygeneral.gov, or 814-863-0684

https://www.naddi.org/events/2022-naddi-pennsylvania-chapter-training-conference-save-the-date/

Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by calling 814-889-2226.

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine.  Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.